Developed in exclusive collaboration with Hypatia, led by former Google engineer David Gordon, the asset leverages AI language.

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

From 2023 to 2032, the global Bioanalytical Services market is projected to experience significant growth, driven by advancements in technology, increasing regulatory scrutiny, and the expanding ...

In a new study, a team of researchers, including Anneliene Jonker, has published, in Nature Reviews Drug Discovery, the first ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that its third batch of pharm ...

Relying less on animal testing for new drugs and more on lab-made “organoids” designed to mimic the functions of human organs ...

Scientists stress out lab mice, a lot. Inducing chronic stress and anxiety in these furry critters is how scientists explore ...

While there have been substantial advancements in the field of oncology and the treatment of the disease, keeping the cancer rate in the country below that of several others, several gaps persist ...

MaxCyte now expects full year 2024 core business revenue of at least 5% growth compared to 2023. SPL Program-related revenue is expected to be approximately $6 million. The outlook for the full year ...

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $140 million in its third quarter. The Carlsbad, California-based company said it had ...

For people suffering from various rare forms of blood cancer, acalabrutinib offers the promise of improved life quality by reducing serious side effects — namely suppressed immune systems that left ...

A survey of a waterway on Wurundjeri land has led to the discovery of new viruses that kill the superbug Klebsiella.